268 related articles for article (PubMed ID: 23147477)
1. Anemia in heart failure: association of hepcidin levels to iron deficiency in stable outpatients.
Weber CS; Beck-da-Silva L; Goldraich LA; Biolo A; Clausell N
Acta Haematol; 2013; 129(1):55-61. PubMed ID: 23147477
[TBL] [Abstract][Full Text] [Related]
2. Hepcidin and hemoglobin content parameters in the diagnosis of iron deficiency in rheumatoid arthritis patients with anemia.
van Santen S; van Dongen-Lases EC; de Vegt F; Laarakkers CM; van Riel PL; van Ede AE; Swinkels DW
Arthritis Rheum; 2011 Dec; 63(12):3672-80. PubMed ID: 22127690
[TBL] [Abstract][Full Text] [Related]
3. Soluble TNFα receptor type I and hepcidin as determinants of development of anemia in the long-term follow-up of heart failure patients.
Martínez-Ruiz A; Tornel-Osorio PL; Sánchez-Más J; Pérez-Fornieles J; Vílchez JA; Martínez-Hernández P; Pascual-Figal DA
Clin Biochem; 2012 Nov; 45(16-17):1455-8. PubMed ID: 22609894
[TBL] [Abstract][Full Text] [Related]
4. Iron metabolism, hepcidin, and anemia in orthotopic heart transplantation recipients treated with mammalian target of rapamycin.
Przybylowski P; Malyszko JS; Macdougall IC; Malyszko J
Transplant Proc; 2013; 45(1):387-90. PubMed ID: 23375326
[TBL] [Abstract][Full Text] [Related]
5. Serum pro-hepcidin level and iron homeostasis in Japanese dialysis patients with erythropoietin (EPO)-resistant anemia.
Shinzato T; Abe K; Furusu A; Harada T; Shinzato K; Miyazaki M; Kohno S
Med Sci Monit; 2008 Sep; 14(9):CR431-7. PubMed ID: 18758412
[TBL] [Abstract][Full Text] [Related]
6. Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival.
Okonko DO; Mandal AK; Missouris CG; Poole-Wilson PA
J Am Coll Cardiol; 2011 Sep; 58(12):1241-51. PubMed ID: 21903058
[TBL] [Abstract][Full Text] [Related]
7. Is hepcidin a link between anemia, inflammation and liver function in hemodialyzed patients?
Małyszko J; Małyszko JS; Hryszko T; Pawlak K; Mysliwiec M
Am J Nephrol; 2005; 25(6):586-90. PubMed ID: 16254410
[TBL] [Abstract][Full Text] [Related]
8. Is hepcidin-25 a clinically relevant parameter for the iron status in hemodialysis patients?
Brătescu LO; Bârsan L; Munteanu D; Stancu S; Mircescu G
J Ren Nutr; 2010 Sep; 20(5 Suppl):S77-83. PubMed ID: 20797577
[TBL] [Abstract][Full Text] [Related]
9. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial.
Okonko DO; Grzeslo A; Witkowski T; Mandal AK; Slater RM; Roughton M; Foldes G; Thum T; Majda J; Banasiak W; Missouris CG; Poole-Wilson PA; Anker SD; Ponikowski P
J Am Coll Cardiol; 2008 Jan; 51(2):103-12. PubMed ID: 18191732
[TBL] [Abstract][Full Text] [Related]
10. Hepcidin and iron deficiency in pre-kidney transplant patients.
Sancho A; Pastor MC; Troya M; Bonal J; Bayés B; Morales-Indiano C; Lauzurica R; Romero R
Transplant Proc; 2009; 41(6):2079-81. PubMed ID: 19715836
[TBL] [Abstract][Full Text] [Related]
11. Serum hepcidin-25 levels and anemia in non-dialysis chronic kidney disease patients: a cross-sectional study.
Uehata T; Tomosugi N; Shoji T; Sakaguchi Y; Suzuki A; Kaneko T; Okada N; Yamamoto R; Nagasawa Y; Kato K; Isaka Y; Rakugi H; Tsubakihara Y
Nephrol Dial Transplant; 2012 Mar; 27(3):1076-83. PubMed ID: 21799206
[TBL] [Abstract][Full Text] [Related]
12. Decreased serum hepcidin and improved functional iron status 6 months after restrictive bariatric surgery.
Tussing-Humphreys LM; Nemeth E; Fantuzzi G; Freels S; Holterman AX; Galvani C; Ayloo S; Vitello J; Braunschweig C
Obesity (Silver Spring); 2010 Oct; 18(10):2010-6. PubMed ID: 20075851
[TBL] [Abstract][Full Text] [Related]
13. Increased hepcidin-25 and erythropoietin responsiveness in patients with cardio-renal anemia syndrome.
Kato A
Future Cardiol; 2010 Nov; 6(6):769-71. PubMed ID: 21142632
[TBL] [Abstract][Full Text] [Related]
14. Serum hepcidin concentration in chronic haemodialysis patients: associations and effects of dialysis, iron and erythropoietin therapy.
Weiss G; Theurl I; Eder S; Koppelstaetter C; Kurz K; Sonnweber T; Kobold U; Mayer G
Eur J Clin Invest; 2009 Oct; 39(10):883-90. PubMed ID: 19563467
[TBL] [Abstract][Full Text] [Related]
15. Regulation of hepcidin: insights from biochemical analyses on human serum samples.
Kemna EH; Kartikasari AE; van Tits LJ; Pickkers P; Tjalsma H; Swinkels DW
Blood Cells Mol Dis; 2008; 40(3):339-46. PubMed ID: 18023212
[TBL] [Abstract][Full Text] [Related]
16. Elevated systemic hepcidin and iron depletion in obese premenopausal females.
Tussing-Humphreys LM; Nemeth E; Fantuzzi G; Freels S; Guzman G; Holterman AX; Braunschweig C
Obesity (Silver Spring); 2010 Jul; 18(7):1449-56. PubMed ID: 19816411
[TBL] [Abstract][Full Text] [Related]
17. Hepcidin and iron status among pregnant women in Bangladesh.
Schulze KJ; Christian P; Ruczinski I; Ray AL; Nath A; Wu LS; Semba RD
Asia Pac J Clin Nutr; 2008; 17(3):451-6. PubMed ID: 18818166
[TBL] [Abstract][Full Text] [Related]
18. Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency.
Usmanov RI; Zueva EB; Silverberg DS; Shaked M
J Nephrol; 2008; 21(2):236-42. PubMed ID: 18446719
[TBL] [Abstract][Full Text] [Related]
19. The role of hepcidin in iron homeostasis and anemia in hemodialysis patients.
Eleftheriadis T; Liakopoulos V; Antoniadi G; Kartsios C; Stefanidis I
Semin Dial; 2009; 22(1):70-7. PubMed ID: 19250447
[TBL] [Abstract][Full Text] [Related]
20. Heart and iron deficiency anaemia in rats with renal insufficiency: the role of hepcidin.
Toblli JE; Cao G; Rivas C; Kulaksiz H
Nephrology (Carlton); 2008 Oct; 13(7):636-45. PubMed ID: 18808386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]